Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of metabolic disorders. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://caoimhebbqe758941.bloggazza.com/37794712/retaglutide-a-promising-glp-1-receptor-agonist